Abstract
Background: In the older population, multimorbidity is common and ‘best practice’ may invite the prescription of multiple medications.
Objective: To examine the association between polypharmacy, defined as the concurrent use of five or more prescription or nonprescription medications, and mortality in 12 423 participants aged ≥65 years representative of the older population of England and Wales.
Methods: Data on self-reported medication use, disability and health conditions were collected at baseline in 1991–3. The cohort was followed for up to 18 years with full mortality notification. Cox proportional hazards regression adjusted for age, baseline institutionalization, smoking, disability and health conditions was used to investigate polypharmacy and mortality, stratified by sex. Various methods for modelling the time-varying effect of polypharmacy are presented.
Results: A strong independent association between polypharmacy and mortality existed in the short-term (first 2 years) for both men and women. This association remained, although attenuated, in the medium-long term (2–18 years of follow-up) for women, but became non-significant in the longer term for men.
Conclusions: It remains unclear whether polypharmacy is a marker for poor health or is an independent risk factor for mortality. However, polypharmacy strongly predicts adverse outcomes, and multiple medication use should therefore be carefully monitored in the older population.
Similar content being viewed by others
References
Department of Economic and Social Affairs. Population ageing and development 2009 (Wall Chart). In: Department of Economic and Social Affairs, editors. Population studies. Vol. 290. 290th ed. New York: United Nations, 2010
van den Akker M, Buntinx F, Metsemakers JF, et al. Multi-morbidity in general practice: prevalence, incidence, and determinants of co-occurring chronic and recurrent diseases. J Clin Epidemiol 1998 May; 51(5): 367–75
Jorgensen T, Johansson S, Kennerfalk A, et al. Prescription drug use, diagnoses, and healthcare utilization among the elderly. Ann Pharmacother 2001 Sep; 35(9): 1004–9
Lapi F, Pozzi C, Mazzaglia G, et al. Epidemiology of sub-optimal prescribing in older, community dwellers: a two-wave, population-based survey in Dicomano, Italy. Drugs Aging 2009; 26(12): 1029–38
Families USA. Cost overdose: growth in drug spending for the elderly, 1992–2010. In: Families USA, ed. no. 00-107. Washington, DC: Families USA Foundation, 2000
Royal College of Physicians. Medication for older people: summary and recommendations of a report of a working party of The Royal College of Physicians. J R Coll Physicians Lond 1997 May–Jun; 31(3): 254–7
Gorard DA. Escalating polypharmacy. Q J Med 2006 Nov; 99(11): 797–800
Hajjar ER, Cafiero AC, Hanlon JT. Polypharmacy in elderly patients. Am J Geriatr Pharmacother 2007 Dec; 5(4): 345–51
Fulton MM, Allen ER. Polypharmacy in the elderly: a literature review. J Am Acad Nurse Pract 2005 Apr; 17(4): 123–32
Mansur N, Weiss A, Beloosesky Y. Relationship of in-hospital medication modifications of elderly patients to postdischarge medications, adherence, and mortality. Ann Pharmacother 2008 Jun; 42(6): 783–9
Frazier SC. Health outcomes and polypharmacy in elderly individuals: an integrated literature review. J Gerontol Nurs 2005 Sep; 31(9): 4–11
Hilmer SN, Gnjidic D. The effects of polypharmacy in older adults. Clin Pharmacol Ther 2009 Jan; 85(1): 86–8
Espino DV, Bazaldua OV, Palmer RF, et al. Suboptimal medication use and mortality in an older adult community-based cohort: results from the Hispanic EPESE Study. J Gerontol A Biol Sci Med Sci 2006 Feb; 61(2): 170–5
Alarcon T, Barcena A, Gonzalez-Montalvo JI, et al. Factors predictive of outcome on admission to an acute geriatric ward. Age Ageing 1999 Sep; 28(5): 429–32
Iwata M, Kuzuya M, Kitagawa Y, et al. Underappreciated predictors for postdischarge mortality in acute hospitalized oldest-old patients. Gerontology 2006; 52(2): 92–8
Jyrkkä J, Enlund H, Korhonen MJ, et al. Polypharmacy status as an indicator of mortality in an elderly population. Drugs Aging 2009; 26(12): 1039–48
Brayne C, McCracken C, Matthews FE. Cohort profile: the Medical Research Council Cognitive Function and Ageing Study (CFAS). Int J Epidemiol 2006 Oct; 35(5): 1140–5
Cognitive function and dementia in six areas of England and Wales: the distribution of MMSE and prevalence of GMS organicity level in the MRC CFA Study. The Medical Research Council Cognitive Function and Ageing Study (MRC CFAS). Psychol Med 1998 Mar; 28(2): 319–35
Folstein MF, Folstein SE, McHugh PR. ‘Mini-mental state’: a practical method for grading the cognitive state of patients for the clinician. J Psychiatr Res 1975 Nov; 12(3): 189–98
Chen YF, Dewey ME, Avery AJ. Self-reported medication use for older people in England and Wales. J Clin Pharm Ther 2001 Apr; 26(2): 129–40
NHS Centre for Coding and Classification. The read codes: drug and appliance dictionary general information. Loughborough, UK: NHS Centre for Coding and Classification, 1998
Schoenfeld D. Partial residuals for the proportional hazards regression-model. Biometrika 1982; 69(1): 239–41
Moreau T, Oquigley J, Mesbah M. A global goodness-of-fit statistic for the proportional hazards model. Appl Stat J Royal Stat Soc Series C 1985; 34(3): 212–8
Akaike H. New look at statistical-model identification. IEEE Trans Automat Control 1974; Ac19(6): 716–23
Noize P, Bazin F, Dufouil C, et al. Comparison of health insurance claims and patient interviews in assessing drug use: data from the Three-City (3C) Study. Pharmacoepidemiol Drug Saf 2009 Apr; 18(4): 310–9
Boudreau DM, Daling JR, Malone KE, et al. A validation study of patient interview data and pharmacy records for antihypertensive, statin, and antidepressant medication use among older women. Am J Epidemiol 2004 Feb 1; 159(3): 308–17
Caskie GI, Willis SL. Congruence of self-reported medications with pharmacy prescription records in low-income older adults. Gerontologist 2004 Apr; 44(2): 176–85
Ernst E. Herb-drug interactions: potentially important but woefully under-researched. Eur J Clin Pharmacol 2000 Nov; 56(8): 523–4
Okura Y, Urban LH, Mahoney DW, et al. Agreement between self-report questionnaires and medical record data was substantial for diabetes, hypertension, myocardial infarction and stroke but not for heart failure. J Clin Epidemiol 2004 Oct; 57(10): 1096–103
Kriegsman DM, Penninx BW, van Eijk JT, et al. Self-reports and general practitioner information on the presence of chronic diseases in community dwelling elderly: a study on the accuracy of patients’ self-reports and on determinants of inaccuracy. J Clin Epidemiol 1996 Dec; 49(12): 1407–17
Ferraro KF, Su YP. Physician-evaluated and self-reported morbidity for predicting disability. Am J Public Health 2000 Jan; 90(1): 103–8
Bayliss EA, Ellis JL, Steiner JF. Subjective assessments of comorbidity correlate with quality of life health outcomes: initial validation of a comorbidity assessment instrument. Health Qual Life Outcomes 2005; 3: 51
Ferraro KF, Farmer MM. Utility of health data from social surveys: is there a gold standard for measuring morbidity? Am Sociol Rev 1999; 64(2): 303–15
Griffin JP, Griffin TD. The economic implications of therapeutic conservatism. J R Coll Physicians Lond 1993 Apr; 27(2): 121–6
Aparasu RR, Sitzman SJ. Inappropriate prescribing for elderly outpatients. Am J Health Syst Pharm 1999 Mar 1; 56(5): 433–9
Wu JY, Leung WY, Chang S, et al. Effectiveness of telephone counselling by a pharmacist in reducing mortality in patients receiving polypharmacy: randomised controlled trial. BMJ 2006 Sep 9; 333(7567): 522–5
Verbrugge LM. Gender and health: an update on hypotheses and evidence. J Health Soc Behav 1985 Sep; 26(3): 156–82
Anderson GD. Gender differences in pharmacological response. Int Rev Neurobiol 2008; 83: 1–10
Osterberg L, Blaschke T. Adherence to medication. N Engl J Med 2005 Aug 4; 353(5): 487–97
Carbonin P, Pahor M, Bernabei R, et al. Is age an independent risk factor of adverse drug reactions in hospitalized medical patients? J Am Geriatr Soc 1991 Nov; 39(11): 1093–9
Abrahamowicz M, MacKenzie T, Esdaile JM. Time-dependent hazard ratio: modeling and hypothesis testing with application in lupus nephritis. J Am Stat Assoc 1996 Dec; 91(436): 1432–9
Quantin C, Abrahamowicz M, Moreau T, et al. Variation over time of the effects of prognostic factors in a population-based study of colon cancer: comparison of statistical models. Am J Epidemiol 1999 Dec 1; 150(11): 1188–200
George J, Elliott RA, Stewart DC. A systematic review of interventions to improve medication taking in elderly patients prescribed multiple medications. Drugs Aging 2008; 25(4): 307–24
Acknowledgements
The Cognitive Function and Ageing Study (CFAS) is funded by the Medical Research Council (MRC), UK. FM is funded by the UK Medical Research Council (U.1052.00.0013). We are grateful to the respondents, their families and their family practices for all their help in the study. The MRC CFAS is a member study of the Cambridgeshire and Peterborough Collaboration for Leadership in Applied Health Research & Care (CLAHRC). The funders had no role in the preparation of this article. The authors have no conflicts of interests relevant to the content of this study.
Author information
Authors and Affiliations
Corresponding author
Additional information
Joint first authors.
Rights and permissions
About this article
Cite this article
Richardson, K., Ananou, A., Lafortune, L. et al. Variation Over Time in the Association between Polypharmacy and Mortality in the Older Population. Drugs Aging 28, 547–560 (2011). https://doi.org/10.2165/11592000-000000000-00000
Published:
Issue Date:
DOI: https://doi.org/10.2165/11592000-000000000-00000